
Bruker Corporation BRKR
$ 39.83
-0.15%
Quarterly report 2025-Q3
added 11-05-2025
Bruker Corporation EV - Enterprise Value 2011-2026 | BRKR
Annual EV - Enterprise Value Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.81 B | 2.35 B | 1.83 B | -1.07 B | 10.2 B | 9.03 B | 6.41 B | 6.48 B | 4.5 B | 4.49 B | 3.94 B | 4.15 B | 3.62 B | 3.15 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.2 B | -1.07 B | 4.49 B |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | ||
|
Alphatec Holdings
ATEC
|
1.91 B | $ 13.73 | -2.21 % | $ 2.06 B | ||
|
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | ||
|
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M | ||
|
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | ||
|
AxoGen
AXGN
|
1.55 B | $ 31.12 | -0.34 % | $ 1.43 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | ||
|
Cognyte Software Ltd.
CGNT
|
994 M | $ 6.82 | 2.95 % | $ 490 M | ||
|
Aziyo Biologics
AZYO
|
89.6 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
54.4 M | $ 3.44 | 0.58 % | $ 119 M | ||
|
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
459 M | $ 12.98 | -14.39 % | $ 351 M | ||
|
Bio-Rad Laboratories
BIO
|
10.1 B | $ 270.55 | 0.41 % | $ 7.63 B | ||
|
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | ||
|
BioSig Technologies
BSGM
|
9.42 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
111 B | $ 74.69 | 1.66 % | $ 111 B | ||
|
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
252 M | $ 4.5 | -1.96 % | $ 168 M | ||
|
Electromed
ELMD
|
170 M | $ 24.17 | 1.05 % | $ 204 M | ||
|
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | ||
|
CONMED Corporation
CNMD
|
2.57 B | $ 46.25 | 0.61 % | $ 1.44 B | ||
|
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | ||
|
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
639 M | - | - | $ 111 M | ||
|
Cutera
CUTR
|
421 M | - | -10.19 % | $ 1.99 M | ||
|
Delcath Systems
DCTH
|
350 M | $ 9.28 | -9.16 % | $ 265 M | ||
|
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | ||
|
InMode Ltd.
INMD
|
3.99 B | $ 13.91 | -0.39 % | $ 899 M | ||
|
Second Sight Medical Products
EYES
|
5.82 M | - | -0.97 % | $ 54.4 M | ||
|
IRIDEX Corporation
IRIX
|
65.9 M | $ 1.47 | -2.0 % | $ 23.7 M | ||
|
IRadimed Corporation
IRMD
|
629 M | $ 100.65 | 0.15 % | $ 1.28 B | ||
|
Establishment Labs Holdings
ESTA
|
1.41 B | $ 75.32 | -3.79 % | $ 2.12 B | ||
|
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | ||
|
FONAR Corporation
FONR
|
91.5 M | $ 18.54 | -0.22 % | $ 122 M | ||
|
LivaNova PLC
LIVN
|
4.58 B | $ 70.57 | 0.4 % | $ 3.85 B | ||
|
Globus Medical
GMED
|
12.7 B | $ 95.47 | -0.77 % | $ 12.9 B | ||
|
Medtronic PLC
MDT
|
152 B | $ 96.23 | -0.44 % | $ 124 B | ||
|
MiMedx Group
MDXG
|
699 M | $ 4.89 | -7.48 % | $ 723 M | ||
|
Pulmonx Corporation
LUNG
|
347 M | $ 1.56 | -4.6 % | $ 61 M | ||
|
Helius Medical Technologies
HSDT
|
3.7 M | $ 1.91 | -12.07 % | $ 1.16 M | ||
|
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M |